Stanford Medicine researchers are hopeful that a proof-of-concept treatment in mice—blood stem cell transplants—may reduce signs of Alzheimer’s disease.
Stanford Medicine researchers are hopeful that a proof-of-concept treatment in mice—blood stem cell transplants—may reduce signs of Alzheimer’s disease.